Resources
Information on PSCI and resource materials on pharmaceutical supply chain sustainability
The resources are particularly targeted at companies working in the supply chain – our suppliers – who are warmly encouraged to make free use of all the materials here.
We will continue to build this section over time. If you have any suggestions on how we can improve it please contact us.
Key Resources
Search for a resource by typing a word or phrase into the search box.
Filter by topic, target audience and category by clicking each of the filter buttons and choosing a filter from the list that appears. Show me
GHS - basic training
Info session Globally Harmonized System of Classification and Labelling of chemicals
Labs - testing performance hoods isolators
Testing Fume Hoods & Isolators
Chemical Production & Development site Geel
Michel Vangeel – EHS Department – October 2010
UNGC Fighting Corruption in the Supply Chain
The UN Global Compact’s Fighting Corruption in the Supply Chain: A Guide for Customers and Suppliers outlines why businesses must join the fight against corruption and provides pragmatic advice on addressing this complex challenge.
Example Risk Assessment and Monitoring Program CP
Chemical Risk Assessment & Exposure Monitoring
Chemical Production & Development Janssen Pharma Geel Belgium
Michel Vangeel - Prevention Department
Group Code of Conduct
The Roche Group Code of Conduct is designed to guide business behaviour and provides useful links to further information.
K15 Directive - Dealing with Third Party Manufacturers
The Roche Group Directive K15 concerning dealing with Third Party Manufacturers and Service Providers.
Human Rights Position
Example: Bayer's position on Human Rights and its commitments to implement them.
Containment Testing Protocol
Industrial Hygiene FAT and SAT Performance Evaluation Protocol
Bioethics Clinical Trials
Bioethics at Novo Nordisk. It is the expression used for all ethical issues related to the use of life science technologies in the discovery, development and production of pharmaceutical products. This covers the ethical aspects of the use of human biological material, animals and gene technology in research, and clinical trials.
Example Chemical Risk Assessment and Exposure Monitoring Program
Chemical Risk Assessment and Exposure Monitoring Program
Labeling and identification of hazardous substances
Labeling and identification of hazardous substances and preparations
Example analytical method Ceftobiprole
This report describes an air sampling and analytical method for the determination of airborne Ceftobiprole medocaril (BAL 5788). This method was developed and evaluated by the Catholic University of Leuven at the request of Janssen Pharmaceutica Beerse (Belgium).
Written Respiratory Protection Program
This respiratory protection program has been established to provide uniform and consistent procedures for those needing to wear respirators, either in the regular course of their duties or in emergencies. The program includes requirements for medical evaluation, training, and fit-testing of wearers; control of respirator selection, inspection, and maintenance; and recordkeeping. Standard operating procedures are included within, or attached to, this program.
Storage of chemicals in laboratories - compatibility basic rules
Storage of chemicals in laboratories - compatibility basic rules
Responsible Sourcing Standards
Novo Nordisk's Responsible Sourcing Programme. The standards are classified into six categories: general compliance with laws and regulations, health & safety, labour practices, ethics, environment, and sub-suppliers.
Example IH report Cilag
Dust Measurements during Charging and Discharging of the mechanical Dryer in Building 20 of TIC 1097 in ILC-Dover G2PacTM
Example Action Plan Physical Agents
PowerPoint covering "Approach Physical Agents Program".
Analytical Method Development Update
Johnson & Johnson
Worldwide Health & Safety
Industrial Hygiene Analytical Method Development